Newsfeeds Archive - Spark Newswire

2 minute read

Evolus Announces Publication Of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau

April 17, 4:13 PM

The article published in Aesthetic Surgery Journal supports safety and duration of effect for temporary improvement in the appearance of moderate to severe glabellar lines presented at the 2023 ASDS Annual MeetingData

EOLS

3 minute read

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

January 29, 3:09 PM

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

ACON

2 minute read

SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday

By Avi Kapoor

January 29, 11:31 AM

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.

CDLX

2 minute read

Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Alternative Maker

By Vandana Singh

January 17, 4:55 PM

Evolus beats Q4 revenue expectations, up 40% YoY at $61M. Full-year 2023 hits $202M, exceeding guidance. Analysts bullish on Evolus.

EOLS

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

January 17, 1:31 PM

Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 26.1% to $3.33 during Wednesday’s regular session. The company’s market…

ACXP

2 minute read

Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition

By Vandana Singh

January 11, 9:31 AM

AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing potential risks, AbbVie emphasizes its commitment to safety with existing 'black box' warnings. Amidst economic uncertainties and emerging competitors, AbbVie anticipates continued strength.

ABBV

4 minute read

Evolus Enters Into Licensing Agreement With Symatese To Exclusively Distribute Next-Generation Dermal Fillers In Europe; Evolus Will Pre-Announce Preliminary, Unaudited Q4 And FY23 Results And Revenue Guidance For 2024 In January

By Benzinga Newsdesk

December 20, 9:04 AM

Exclusive Distributor Agreement with Symatese Broadens Evolus' Dermal Filler Footprint Beyond the U.S. to Include the United Kingdom and EuropeEuropean Regulatory Approvals Anticipated in Second Half of 2024Company

EOLS

1 minute read

Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings

By Vandana Singh

December 12, 3:04 PM

Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to Botox and similar injections.

ABBV

5 minute read

Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

November 8, 2:41 PM

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

ADNT

2 minute read

Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

November 8, 12:02 PM

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.

AGTI